Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients - Malouf,M.A.; Chhajed,P.N.; Hopkins,P.; Plit,M.; Turner,J.; Glanville,A.R. (J Heart Lung Transplant, 2002)